Basics Atyr Pharma, Inc. IPO Date: May 12, 2015 Sector: Healthcare Industry: Biotech Market Cap: $501.09M Activated in VL: True Average Daily Range Avg Daily Range: $0.11 | 3.48% Avg Daily Range (30 D): $0.19 | 3.41% Avg Daily Range (90 D): $0.16 | 3.95% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): 3.66M Avg Daily Volume (90 D): 2.24M Trade Size Avg Trade Size (Sh.): 167 Avg Trade Size (Sh.) (30 D): 173 Avg Trade Size (Sh.) (90 D): 163 Institutional Trades Total Inst.Trades: 64 Avg Inst. Trade: $2.2M Avg Inst. Trade (30 D): $2.41M Avg Inst. Trade (90 D): $2.14M Avg Inst. Trade Volume: .55M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.51M Avg Closing Trade (30 D): $2.96M Avg Closing Trade (90 D): $2.62M Avg Closing Volume: 502.64K     News Jul 18, 2025 @ 8:56 AM RNA Therapeutics and RNA Vaccines Market Industry ... Source: Researchandmarkets.Com Jun 26, 2025 @ 12:00 PM aTyr Pharma to be Added to the Russell 2000® an... Source: Atyr Pharma Dec 9, 2024 @ 1:00 PM aTyr Pharma to Present Preclinical Research Demons... Source: Atyr Pharma Jul 22, 2024 @ 12:05 PM aTyr Pharma Completes Enrollment in Global Pivotal... Source: N/A Jun 18, 2024 @ 1:40 PM Is aTyr Pharma (ATYR) Outperforming Other Medical ... Source: Zacks Equity Research Financials   TTM FY 2024 Q3 2024 Basic EPS $-.17 $-.86 $-.23 Diluted EPS $-.17 $-.86 $-.23 Revenue $ M $ .24M $ M Gross Profit $ $ $ Net Income / Loss $ -14.88M $ -64.02M $ -17.26M Operating Income / Loss $ -15.77M $ -67.91M $ -18.14M Cost of Revenue $ $ $ Net Cash Flow $ -1.21M $ -12.02M $ 4.68M PE Ratio